$CBOE GLOBAL MARKETS Q3’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $712.2M (Est. $706M) 🟢; +18% YoY 🔹 Adj. EPS: $3.63 (Est. $3.43) 🟢; +36% YoY 🔹 GAAP EPS: $4.08; +43% YoY 🔹 Adj. EBITDA: $528.8M; +27% YoY FY26 Guide: 🔹 Organic Total Net Revenue Growth: High teens; from mid to high teens 🔹 Data Vantage Organic Net Revenue Growth: Mid teens; from low teens 🔹 Adj. Oper Expenses: $830M-$845M; from $838M-$853M 🔹 D&A: $54M-$58M; affirmed 🔹 Adjusted Tax Rate: 27.5%-29.5%; affirmed 🔹 CapEx: $98M-$108M; affirmed Segment Net Revenue: 🔹 Options: $469.5M; +23% YoY 🔹 N.A. Equities: $113.5M; +10% YoY 🔹 Europe & APAC: $73.3M; +6% YoY 🔹 Futures: $28.2M; -5% YoY 🔹 Global FX: $27.7M; +23% YoY Capital Return: 🔹 Buybacks: $56.1M; 211K shares 🔹 Dividend: $0.86/share 🔹 Remaining Authorization: $480.7M 🔹 New Authorization: $550M Key Updates: 🔹 S&P License: Exclusive license extended through 2051 🔹 Event Contracts: SEC approvals received; November launch anticipated 🔹 Cboe Predicts: Offering and clearing capabilities advanced Comments: 🔸 “First, we extended our exclusive S&P license through 2051, providing certainty and continuity for our SPX and VIX franchises.” 🔸 “Net revenue in our Derivatives business rose 22 percent, driven by a 24 percent increase in index options average daily volume supported by record 0DTE activity.”